Betaine alleviates MASLD through hepatic N6-methyladenosine (m6A)-dependent translational regulation
Year: 2026
Type: article
Abstract: Background N6-methyladenosine (m6A) methylation is emerging as a key regulator of mRNA translation, but its role in metabolic dysfunction-associated steatotic liver disease (MASLD) remains poorly understood. Whether betaine, a methyl donor, alleviates hepatic steatosis through m6A-mediated translational regulation has not been explored. Methods A high-fat diet (HFD)-induced MASLD mouse model, with or without betaine intervention, was analyzed using integrated multi-omics approaches, followed by in vitro validation. Results Betaine ameliorated HFD-induced hepatic steatosis and liver injury. Integrative analysis revealed betaine-induced alterations in m6A methylation, and genes bearing differential m6A peaks were enriched in lipid metabolism and autophagy pathways. Notably, m6A modifications, particularly in coding regions, were associated with enhanced translation of target genes. Protein-protein interaction (PPI) analysis highlighted ANKHD1 as a hub gene. In vitro , betaine reduced lipid accumulation and enhanced ANKHD1 translation, whereas ANKHD1 knockdown attenuated the lipid-lowering effect of betaine, suggesting a potential role for ANKHD1 in the hepatoprotective action of betaine. Conclusion This study provides a comprehensive characterization of m6A-mediated translational regulation in betaine-induced amelioration of hepatic steatosis. Our findings suggest that the m6A- ANKHD1 axis may contribute to betaine’s beneficial effects on MASLD, and identify ANKHD1 as a potential therapeutic target. These insights may inform nutritional strategies for improving hepatic lipid metabolism in livestock production.
Source: Frontiers in Pharmacology
Language: English
Topic: RNA modifications and cancer
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236382674
